HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ju-Hyun Bae Selected Research

Sulfisoxazole (Sulfafurazole)

1/2022Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD-L1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ju-Hyun Bae Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 01/2021
1Breast Neoplasms (Breast Cancer)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021

Drug/Important Bio-Agent (IBA)

2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2022
1B7-H1 AntigenIBA
01/2022
1Endothelin Receptors (Endothelin Receptor)IBA
01/2022
1macitentanIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Sulfisoxazole (Sulfafurazole)FDA Link
01/2022
1SulfonamidesIBA
01/2022
1PhosphatidylserinesIBA
01/2021
1Gefitinib (Iressa)FDA Link
01/2021

Therapy/Procedure

1Therapeutics
01/2022